Search

Nam V. Nguyen

Examiner (ID: 12891, Phone: (571)272-3061 , Office: P/2682 )

Most Active Art Unit
2682
Art Unit(s)
2685, 2612, 2684, 2682, 2635
Total Applications
1359
Issued Applications
980
Pending Applications
99
Abandoned Applications
302

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16157317 [patent_doc_number] => 20200216891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-09 [patent_title] => NUCLEOSIDES AND NUCLEOTIDES WITH 3'-HYDROXY BLOCKING GROUPS [patent_app_type] => utility [patent_app_number] => 16/724088 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724088 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/724088
Sequencing methods using nucleotides with 3' AOM blocking group Dec 19, 2019 Issued
Array ( [id] => 17045184 [patent_doc_number] => 11098353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-24 [patent_title] => Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators [patent_app_type] => utility [patent_app_number] => 16/722702 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 12 [patent_no_of_words] => 15590 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 436 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16722702 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/722702
Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators Dec 19, 2019 Issued
Array ( [id] => 18701431 [patent_doc_number] => 11787930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => Flow cell including a heteropolymer [patent_app_type] => utility [patent_app_number] => 16/721451 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 14 [patent_no_of_words] => 19040 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721451 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/721451
Flow cell including a heteropolymer Dec 18, 2019 Issued
Array ( [id] => 16893428 [patent_doc_number] => 11034964 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-06-15 [patent_title] => Binding molecules built from L-DNA with added nucleotides [patent_app_type] => utility [patent_app_number] => 16/719232 [patent_app_country] => US [patent_app_date] => 2019-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3798 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719232 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/719232
Binding molecules built from L-DNA with added nucleotides Dec 17, 2019 Issued
Array ( [id] => 15866147 [patent_doc_number] => 20200140477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY [patent_app_type] => utility [patent_app_number] => 16/714595 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17457 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16714595 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/714595
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway Dec 12, 2019 Issued
Array ( [id] => 17370380 [patent_doc_number] => 20220025432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => METHOD FOR FLUORESCENCE LABELING OF BIOLOGICAL MATERIALS, THERMALLY REMOVABLE FLUORESCENT LABELS FOR THIS METHOD, AND METHODS OF THEIR PREPARATION AND USE [patent_app_type] => utility [patent_app_number] => 17/311678 [patent_app_country] => US [patent_app_date] => 2019-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15762 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311678 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/311678
METHOD FOR FLUORESCENCE LABELING OF BIOLOGICAL MATERIALS, THERMALLY REMOVABLE FLUORESCENT LABELS FOR THIS METHOD, AND METHODS OF THEIR PREPARATION AND USE Dec 2, 2019 Abandoned
Array ( [id] => 16177289 [patent_doc_number] => 20200224257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => QUENCHER AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/700618 [patent_app_country] => US [patent_app_date] => 2019-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9239 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 378 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700618 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/700618
Quencher and use thereof Dec 1, 2019 Issued
Array ( [id] => 15649613 [patent_doc_number] => 20200087336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-19 [patent_title] => LABELLED NUCLEOTIDES [patent_app_type] => utility [patent_app_number] => 16/691108 [patent_app_country] => US [patent_app_date] => 2019-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11893 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691108 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/691108
LABELLED NUCLEOTIDES Nov 20, 2019 Abandoned
Array ( [id] => 15931959 [patent_doc_number] => 20200157613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => CHROMOGENIC PEROXIDASE SUBSTRATES [patent_app_type] => utility [patent_app_number] => 16/688076 [patent_app_country] => US [patent_app_date] => 2019-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27704 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16688076 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/688076
Chromogenic peroxidase substrates Nov 18, 2019 Issued
Array ( [id] => 15711153 [patent_doc_number] => 20200102342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-02 [patent_title] => PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY [patent_app_type] => utility [patent_app_number] => 16/687356 [patent_app_country] => US [patent_app_date] => 2019-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17447 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16687356 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/687356
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway Nov 17, 2019 Issued
Array ( [id] => 15590441 [patent_doc_number] => 20200071755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => Methods and Compositions for Incorporating Nucleotides [patent_app_type] => utility [patent_app_number] => 16/674341 [patent_app_country] => US [patent_app_date] => 2019-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31390 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16674341 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/674341
Methods and compositions for incorporating nucleotides Nov 4, 2019 Issued
Array ( [id] => 19579864 [patent_doc_number] => 12145960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-19 [patent_title] => Nucleotide analogues [patent_app_type] => utility [patent_app_number] => 17/287255 [patent_app_country] => US [patent_app_date] => 2019-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 77581 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287255 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/287255
Nucleotide analogues Oct 23, 2019 Issued
Array ( [id] => 16230534 [patent_doc_number] => 10738072 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-08-11 [patent_title] => Nucleotide analogues [patent_app_type] => utility [patent_app_number] => 16/662781 [patent_app_country] => US [patent_app_date] => 2019-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 77560 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16662781 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/662781
Nucleotide analogues Oct 23, 2019 Issued
Array ( [id] => 17998090 [patent_doc_number] => 11499186 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-15 [patent_title] => DNA sequencing by synthesis using modified nucleotides and nanopore detection [patent_app_type] => utility [patent_app_number] => 16/653278 [patent_app_country] => US [patent_app_date] => 2019-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 26773 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 505 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16653278 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/653278
DNA sequencing by synthesis using modified nucleotides and nanopore detection Oct 14, 2019 Issued
Array ( [id] => 15769441 [patent_doc_number] => 20200115738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => MECHANICALLY-STRAINED OLIGONUCLEOTIDE CONSTRUCTS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/601246 [patent_app_country] => US [patent_app_date] => 2019-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10356 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16601246 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/601246
Mechanically-strained oligonucleotide constructs and methods of using the same Oct 13, 2019 Issued
Array ( [id] => 15455135 [patent_doc_number] => 20200040392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => METHOD FOR LABELING OF ALDEHYDE CONTAINING TARGET MOLECULES [patent_app_type] => utility [patent_app_number] => 16/596539 [patent_app_country] => US [patent_app_date] => 2019-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11310 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16596539 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/596539
Method for labeling of aldehyde containing target molecules Oct 7, 2019 Issued
Array ( [id] => 15741121 [patent_doc_number] => 20200109448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-09 [patent_title] => LABELLED NUCLEOTIDES [patent_app_type] => utility [patent_app_number] => 16/593512 [patent_app_country] => US [patent_app_date] => 2019-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7508 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16593512 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/593512
LABELLED NUCLEOTIDES Oct 3, 2019 Abandoned
Array ( [id] => 18575778 [patent_doc_number] => 11732294 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-22 [patent_title] => Polynucleotides, reagents, and methods for nucleic acid hybridization [patent_app_type] => utility [patent_app_number] => 16/590301 [patent_app_country] => US [patent_app_date] => 2019-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 113 [patent_no_of_words] => 47000 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16590301 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/590301
Polynucleotides, reagents, and methods for nucleic acid hybridization Sep 30, 2019 Issued
16/572078 Directed transliteration of nucleotides in DNA Sep 15, 2019
Array ( [id] => 16663857 [patent_doc_number] => 10933079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-02 [patent_title] => Oligonucleotide analogues incorporating 5-aza-cytosine therein [patent_app_type] => utility [patent_app_number] => 16/571564 [patent_app_country] => US [patent_app_date] => 2019-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 22046 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16571564 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/571564
Oligonucleotide analogues incorporating 5-aza-cytosine therein Sep 15, 2019 Issued
Menu